146471-75-2 Usage
Uses
Used in Pharmaceutical Industry:
(1R,3R)-2-benzyl-5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol is used as a pharmaceutical agent for its potential therapeutic effects. (1R,3R)-2-benzyl-5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol's unique structure and functional groups may contribute to its interaction with biological targets, such as receptors, enzymes, or other proteins, leading to potential applications in the treatment of various diseases or conditions.
Used in Medicinal Chemistry Research:
(1R,3R)-2-benzyl-5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol serves as a valuable compound in medicinal chemistry research. Its specific properties and potential biological activities make it an interesting subject for studying the structure-activity relationship, optimization of drug candidates, and the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 146471-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,4,7 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 146471-75:
(8*1)+(7*4)+(6*6)+(5*4)+(4*7)+(3*1)+(2*7)+(1*5)=142
142 % 10 = 2
So 146471-75-2 is a valid CAS Registry Number.
146471-75-2Relevant articles and documents
First synthesis of the antimalarial naphthylisoquinoline alkaloid dioncophylline C, and its unnatural anti-HIV dimer, jozimine C1
Bringmann, Gerhard,Holenz, Joerg,Weirich, Ralf,Ruebenacker, Martin,Funke, Christian,Boyd, Michael R.,Gulakowski, Robert J.,Francois, Guido
, p. 497 - 512 (1998)
The first total synthesis of dioncophylline C, a new antimalarial lead structure, is described. For the directed construction of the stereogenic biaryl axis, the 'lactone methodology' is applied, despite the lack of a 'bridgehead oxygen' function in the t